UpHealth, Inc. at its annual stockholder meeting, held December 5, 2022, appointed Mr. Mark Guinan, who will also serve as the chair of Audit Committee, and Mr. Luis Machuca, to the board of directors in addition to recently appointed CEO. Guinan has served as a director and Chair of the Audit Committee of Myovant Sciences since July 2018 and as its Lead Independent Director since November 2021. From July 2013 until his retirement in July 2022, he was the Executive Vice President and Chief Financial Officer of Quest Diagnostics, a provider of diagnostic information services.

Prior to this time, from 2010 until joining Quest Diagnostics in 2013, Guinan served as the Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc., a manufacturer and provider of medical technologies and related services for the health care industry. Previously, he served in a number of finance and operations roles over a 13-year career at Johnson & Johnson. Machuca has served as a director of Umpqua Bank since 2010 and as Chair of its Compensation Committee since 2015 and was the designated director for its FinTech venture.

He played a key role in Umpqua's Chief Executive Officer succession in 2017, as well as in the pending merger between Umpqua and Columbia Bank. In addition, he has served as a director of Cambia Health Solutions since 2008 and as Cambia's director on the board of Echo Health Ventures, which he chaired from 2019 until 2021. Machuca also serves as an independent director and Chairman of the Board of Saphyre, a private equity-backed FinTech startup.

He is a leader in technology and healthcare with experience in governance, turnarounds, mergers and acquisitions, finance, risk management and talent development.